Entertainment
View All
Barnstormers Theatre Brings Rocky Horror to Halloween
RIDLEY PARK, PA — Just in time for Halloween, The Barnstormers Theater invites audiences to do the Time Warp once again with a special presentation of The Rocky Horror Picture …
Lifestyle
View All
Pennsylvania Certifies New Channel Catfish Record After 35 Years
HARRISBURG, PA — Pennsylvania has certified its first new Channel Catfish fishing record in 35 years after an Allegheny County angler caught a 36-pound, 2-ounce fish in the Allegheny River …
Pennsylvania
View All
Pennsylvania Invests $2 Million in Wine Industry Growth
CHADDS FORD, PA — Pennsylvania is directing $2 million into wine marketing and research, including more than $1 million for a statewide promotional campaign, as the state’s fourth-largest-in-the-nation wine industry …
National
View All
U.S. Steel Approves $3 Billion Pennsylvania Mill Expansion
WASHINGTON, D.C. — U.S. Steel’s board of directors recently approved a nearly $3 billion investment in a new hot strip mill at its Edgar Thomson Plant in Braddock, Pennsylvania, a …
Latest Articles
View All
Orchestra BioMed to Detail Pivotal Heart Device Trials
NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) will outline clinical development plans and upcoming trial milestones for two cardiovascular technologies at a November 12 investor event in …
Annovis Targets 2027 Alzheimer’s Drug Data Readout
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) will present updates on its experimental Alzheimer’s disease treatment buntanetap at a November medical conference in Boston as the Malvern-based biotechnology company …
Carpenter Technology Profit Jumps 28% on Aerospace Demand
PHILADELPHIA, PA — Carpenter Technology Corporation (NYSE: CRS) reported a 28% increase in operating income for its fiscal first quarter as accelerating commercial aerospace demand, higher pricing and manufacturing improvements …
Arbutus Wins FDA Clearance to Resume Hepatitis B Drug Trials
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has received clearance from the U.S. Food and Drug Administration to resume clinical development of its experimental hepatitis B treatment AB-101 in …
Ocugen Sets November 4 Earnings Report as Gene Therapy Advances
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) will report third-quarter 2026 financial results and provide a business update November 4, giving investors an opportunity to assess the Malvern-based biotechnology company’s …